Judith Anne Shizuru insider trades
Open-market stock purchases and sales by Judith Anne Shizuru, Director at Jasper Therapeutics, Inc, from SEC Form 4 filings since Mar 21, 2022.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -83%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- JSPR Jasper Therapeutics, Inc: 1 buy, last Sep 22, 2025
Get free alerts when Judith Anne Shizuru files a new trade →